Purpose of the Test
- Identifying specific genetic mutations within tumor cells.
- Guiding treatment decisions regarding Tyrosine Kinase Inhibitors (TKIs).
- Evaluating patient eligibility for modern targeted therapies.
Book EGFR Mutation Test | Lahalak Medical Platform
This advanced molecular test identifies specific genetic mutations in lung cancer patients, enabling oncologists to select the most effective targeted therapies and personalized treatment plans for improved clinical outcomes.
Scientific name: Epidermal Growth Factor Receptor (EGFR) Mutation Analysis
A specialized molecular test detecting EGFR gene mutations (including Exon 19 and L858R). It guides tyrosine kinase inhibitor (TKI) therapy to ensure optimal treatment response for oncology patients.
Service type
Molecular Genetic Analysis
Duration
30-45 minutes
Fasting
Fasting is not required
Included Services
- Sample collection or biopsy processing
- Genetic mutation sequencing
- Detailed medical result report
Medical Service Information
Target Groups
- Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC).
- Candidates for first-line targeted therapy protocols.
- Patients showing clinical resistance to standard treatments.
Analyzed Mutations
- Exon 19 deletions (most common sensitizing mutations).
- Exon 21 L858R point mutations.
- Resistance mutations such as T790M for treatment monitoring.
Conditions & Notices
- Provide previous histology reports
- Prior coordination with the treating oncologist
Medical services you might also like
